Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases
Pharmaceuticals · 09.12.2025 · 18 (12) · 1875
DOI: 10.3390/ph18121875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 09.12.2025. Verfasst von Wagdy M Eldehna und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Shaikh 33516, Egypt. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: A promising anticancer strategy is the simultaneous inhibition of the receptor tyrosine kinases VEGFR-2 and c-Met, which are essential for tumor angiogenesis, growth, and metastasis. In this study, a novel series of piperidinyl-based benzoxazole derivatives was designed and synthesized as potential dual VEGFR-2/c-Met inhibitors.
Methods
The kinase inhibitory potential of the derivatives was evaluated in comparison to reference inhibitors, Sorafenib (VEGFR-2 inhibitor) and Staurosporine (c-Met inhibitor). Cytotoxicity was assessed across breast, prostate (PC-3), and lung (A549) cancer cell lines. Mechanistic studies included cell-cycle analysis, apoptosis assays, gene expression profiling of apoptosis-related markers, and molecular docking within the ATP-binding pockets of both kinases.
Results
Compounds 5a, 5g, 5h, 11a, and 11b showed strong inhibition of both kinases (IC50 = 0.145–0.970 μM for VEGFR-2 and 0.181–1.885 μM for c-Met). Selective cytotoxicity was observed against breast cancer cells, with compound 11b (p-fluorophenyl derivative) exhibiting high selectivity toward MCF-7 over normal breast cells (MCF-10A) and potency comparable to or exceeding Sorafenib. Mechanistically, 11b induced G2/M cell-cycle arrest and apoptosis (total apoptosis = 48.34%), accompanied by upregulation of p53, BAX, and caspase-9 and downregulation of Bcl-2. Molecular docking confirmed stable binding within the ATP-binding sites of both kinases.
Conclusions
Compound 11b was established as a novel, selective, dual VEGFR-2/c-Met inhibitor with strong potential for targeted breast cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Shaikh 33516, Egypt.
- Scientific Research and Innovation Support Unit, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Shaikh 33516, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo 11823, Egypt.
- Department of Pharmacology, College of Pharmacy, The Islamic University, Najaf 54001, Iraq.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, International Coastal Road, Gamasa 11152, Egypt.
- Department of Pharmacognosy, College of Pharmacy, King Khalid University, Asir 62521, Saudi Arabia.
ORCID-Profile: Wagdy M Eldehna, Mohamed R Elnagar, Ahmed T Negmeldin, Abdulrahman M Saleh, Ranza Elrayess, Khaled A Elnahriry, Zhi-Long Chen, Mohamed Elagawany, Haytham O Tawfik
Zitieren
APA
Eldehna, W. M., Elsayed, Z. M., Elnagar, M. R., El-Said, A. H., Majrashi, T. A., Negmeldin, A. T., Saleh, A. M., Elrayess, R., Elnahriry, K. A., Chen, Z. L., Elagawany, M., & Tawfik, H. O. (2025). Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases. Pharmaceuticals, 18(12), 1875. https://doi.org/10.3390/ph18121875
Vancouver
Eldehna WM, Elsayed ZM, Elnagar MR, El-Said AH, Majrashi TA, Negmeldin AT, et al. Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases. Pharmaceuticals. 2025;18(12):1875. doi:10.3390/ph18121875
BibTeX
@article{Eldehna2025,
author = {Eldehna, Wagdy M and Elsayed, Zainab M and Elnagar, Mohamed R and El-Said, Ahmed H and Majrashi, Taghreed A and Negmeldin, Ahmed T and Saleh, Abdulrahman M and Elrayess, Ranza and Elnahriry, Khaled A and Chen, Zhi-Long and Elagawany, Mohamed and Tawfik, Haytham O},
title = {Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {12},
pages = {1875},
doi = {10.3390/ph18121875}
}
EUVIMED